Insider trades
Stephen Machatha, Chief Officer of Aldeyra Therapeutics ALDX, has filed 0 purchases and 5 sales on the open market. The latest trade was on 25/08/11.
Stephen Machatha
Chief Development Officer
- Company
- Aldeyra Therapeutics ALDX
- First filing
- 23/03/02
- Trades
- 8 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- No record
- Last trade
- 25/08/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/08/11 | 25/08/13 | 22,073 sh | $5.15 | $113,675.95 | −9.1% | |
| Open-market sale | 24/08/12 | 24/08/14 | 16,041 sh | $4.74 | $76,034.34 | −6.3% | |
| Open-market saleAmendment | 24/03/12 | 24/04/17 | 11,537 sh | $3.16 | $36,456.92 | −4.4% | |
ALDX | Open-market sale | 24/03/11–24/03/12 | 24/03/12 | 29,768 sh2 trades | $3.31avg. | $98,624.63 | −10.9% |